Adial Pharmaceuticals (ADIL) Prepaid Assets (2017 - 2026)
Adial Pharmaceuticals (ADIL) posted Prepaid Assets of $218848.0 for Q1 2026, down 26.97% sequentially from $299666.0 in Q4 2025, and down 16.91% YoY from $263395.0 in Q1 2025.
Adial Pharmaceuticals (ADIL) Prepaid Assets (2017 - 2026) Analysis & Trends
Adial Pharmaceuticals has reported Prepaid Assets for 10 years, with the latest figure at $218848.0 in Q1 2026.
- Quarterly Prepaid Assets fell 16.91% year-over-year to $218848.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $218848.0 (down 16.91% YoY) and the FY2025 annual result came in at $299666.0, down 2.78% from the prior year.
- Prepaid Assets slipped to $218848.0 in Q1 2026 per ADIL's latest filing, from $299666.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $524318.0 in Q3 2023 and troughed at $4430.0 in Q3 2024.
- A 5-year average of $280811.1 and a median of $299666.0 in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets tumbled 99.16% in 2024, then surged 9099.62% in 2025.
- Over 5 years, Prepaid Assets stood at $349441.0 in 2022, then increased by 6.34% to $371597.0 in 2023, then fell by 17.05% to $308239.0 in 2024, then declined by 2.78% to $299666.0 in 2025, then fell by 26.97% to $218848.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $218848.0, $299666.0, and $407543.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Adial Pharmaceuticals | 29.02 Mn | 29.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 218,848.00 |
| Dec 31, 2025 | 299,666.00 |
| Sep 30, 2025 | 407,543.00 |
| Jun 30, 2025 | 163,647.00 |
| Mar 31, 2025 | 263,395.00 |
| Dec 31, 2024 | 308,239.00 |
| Sep 30, 2024 | 4,430.00 |
| Jun 30, 2024 | 346,754.00 |
| Mar 31, 2024 | 275,356.00 |
| Dec 31, 2023 | 371,597.00 |
| Sep 30, 2023 | 524,318.00 |
| Jun 30, 2023 | 91,369.00 |
| Mar 31, 2023 | 428,700.00 |
| Dec 31, 2022 | 349,441.00 |
| Sep 30, 2022 | 516,500.00 |
| Jun 30, 2022 | 194,054.00 |
| Mar 31, 2022 | 9,931.00 |
| Dec 31, 2021 | 9,931.00 |
| Sep 30, 2021 | 235,535.00 |
| Jun 30, 2021 | 147,074.00 |